Try it
Pharmacology · Toxicology and antidotes: zinc in Wilson disease
Sample itemA patient with Wilson disease has been decoppered and is on maintenance therapy with zinc acetate. How does zinc reduce body copper?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. It induces intestinal metallothionein, which binds copper and blocks its absorption
Zinc induces metallothionein in enterocytes. Metallothionein binds copper more avidly than zinc, so copper is trapped in the cell and lost when the cell is shed. Chelators such as penicillamine and trientine instead mobilise copper for urinary excretion.
Option by option
A. It blocks hepatic copper uptake competitively
Zinc acts at the intestine and not by blocking hepatic uptake.
B. It chelates copper in blood for urinary excretion
Chelation for urinary excretion is the action of penicillamine and trientine.
C. It increases biliary copper excretion by upregulating ATP7B
ATP7B is the defective gene in Wilson disease, and zinc does not correct it.
D. It induces intestinal metallothionein, which binds copper and blocks its absorption (correct)
Correct. Metallothionein induction traps dietary copper in enterocytes.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?